Gain Therapeutics, Inc.
GANX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819411
No open-market purchases or sales by Gain Therapeutics, Inc. insiders were filed in the last 90 days; 50 institutions reported holding it in 13F filings for Q2 2026, worth $17.4M in total; Greenlight Capital is the only superinvestor holding it.
Q1 2026 vs. Q4 2025
How the institutions holding Gain Therapeutics, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 48 | 1 | 42 | −5 |
| Shares | 8.06M | 569.9K | 8.19M | +706.6K (+9.4%) |
| Value | $25.9M | $1.84M | $15.8M | −$8.27M (−34.3%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Gain Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 399,886 | $775.8K | 0.00% |
| Vanguard Fiduciary Trust Co | 229,979 | $446.2K | 0.00% |
| Stratos Wealth Partners, LTD. | 131,621 | $255.3K | 0.00% |
| Citadel Advisors LLC | 24,900 | $48.3K | 0.00% |
| Schonfeld Strategic Advisors LLC | 24,500 | $47.5K | 0.00% |
| Vanguard Global Advisers, LLC | 18,376 | $35.6K | 0.00% |
| Millington Financial Advisors, LLC | 15,000 | $29.3K | 0.01% |
| Virtu Financial LLC | 10,685 | $21.0K | 0.00% |
| JPMorgan Chase & Co | 1,700 | $3.06K | 0.00% |
| Citigroup Inc | 1 | $2 | 0.00% |
Sold out (15)
Institutions that held Gain Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Colony Group, LLC | 77,855 | $250.7K |
| HRT Financial LP | 55,679 | $179.0K |
| Omers Administration Corp | 37,300 | $120.1K |
| Goldman Sachs Group Inc | 32,494 | $104.6K |
| Point72 Asset Management, L.P. | 32,480 | $104.6K |
| Lighthouse Investment Partners, LLC | 23,040 | $74.2K |
| Renaissance Technologies LLC | 17,400 | $56.0K |
| Engineers Gate Manager LP | 14,617 | $47.1K |
| Millennium Management LLC | 14,002 | $45.1K |
| Sprott Inc. | 12,000 | $38.6K |
| MAI Capital Management | 4,410 | $14.2K |
| Bank of America Corp | 3,908 | $12.6K |
| BNP Paribas Arbitrage, SA | 2,381 | $7.67K |
| FNY Investment Advisers, LLC | 2,000 | $6.00K |
| State of Wyoming | 1,438 | $4.63K |
Not filed for Q1 2026 yet (1)
Institutions that held Gain Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 569,901 | $1.84M |